| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/29/2005 | CN1633418A Arylalkane-sulfonamides having endothelin-antagonist activity |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/29/2005 | CN1633309A Method of radio-labelling biomolecules |
| 06/29/2005 | CN1633308A Treatment of ophthalmic disorders using urea and urea derivatives |
| 06/29/2005 | CN1633304A Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 06/29/2005 | CN1633302A Method for producing high-quality hydrophobic licorice extract |
| 06/29/2005 | CN1633301A Extracts from sophora, production method and purposes thereof |
| 06/29/2005 | CN1633299A Estrogen replacement therapy |
| 06/29/2005 | CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1633291A 2-oxazolamines and their use as 5-ht2b receptor antagonists |
| 06/29/2005 | CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 06/29/2005 | CN1633289A Hemiasterlin derivatives and uses thereof |
| 06/29/2005 | CN1633284A Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/29/2005 | CN1631895A Preparation method of amygdalin and its application in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound |
| 06/29/2005 | CN1631431A Method for extracting ganoderma lucidum spore fat soluble active substance and its specified instrument for preparation |
| 06/29/2005 | CN1631426A Freeze dried powder injection for treating coronary disease and its preparation process |
| 06/29/2005 | CN1631420A Refined puncturevine fruit saponin capable of being administered by injection, its preparing process and injecta |
| 06/29/2005 | CN1631419A Phacellanthus extractive, its preparation and medical application |
| 06/29/2005 | CN1631395A Gingko leaf sustained release formulation and preparation process thereof |
| 06/29/2005 | CN1631387A Composition with blood pressure regulating function and its product and preparing method |
| 06/29/2005 | CN1631382A Medicine for treating cardiovascular and cerebrovascular diseases |
| 06/29/2005 | CN1631370A Pharmacetutical composition for treating cardiovascular and cerebrovascular disease and its preparing process |
| 06/29/2005 | CN1631364A Application of tanshinone óÄA in pharmacy |
| 06/29/2005 | CN1631361A Application of alpha cyclo-alanine in the process for preparing medicine to treat cerebrovascular and cardiovascular disease |
| 06/29/2005 | CN1208351C Nano crystal cellulose-heparin complex substance and preparing method thereof |
| 06/29/2005 | CN1208336C Tert-butyl-(7-methyl-imidazo [1, 2-a] pyridine-3-yl)-amine derivatives |
| 06/29/2005 | CN1208335C Thiazolidinedione derivative and its use as antidiabetic |
| 06/29/2005 | CN1208333C Indole derivatives useful for the treatment of osteoporosis |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208323C Alpha-substituted carboxylic acid derivatives |
| 06/29/2005 | CN1208322C Dihydroindole and tetrahydroquinoline derivatives |
| 06/29/2005 | CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/29/2005 | CN1208087C Method and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 06/29/2005 | CN1208064C Hyperhydrated citicoline, process and use |
| 06/29/2005 | CN1208051C Medicine against spinal canal restenosis and use thereof |
| 06/28/2005 | US6911542 Pyrazino[1′,2′:1,6]pyrido[3,4b]indole derivatives |
| 06/28/2005 | US6911479 Side effect reduction; purity; removal of stereoisomers |
| 06/28/2005 | US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse |
| 06/28/2005 | US6911452 Central nervous system disorders, sleep disorders, eating disorders. sexual disorders, hypotensive agents |
| 06/28/2005 | US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 |
| 06/28/2005 | US6911440 For the treatment of inflammatory rheumatic/rheumatoid diseases and/or pain, rheumatoid arthritis |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911431 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 06/28/2005 | US6911429 For therapy of arthritis, inflammatory dermatosis, inflammatory bowel disease, cancer, kidney fibrosis, inflammatory lung disease, obesity, lupus, cardiovascular disease and diabetes mellitus |
| 06/28/2005 | US6911426 Inhibitor of apoptosis proteins (IAP); survivin |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/28/2005 | US6911209 Method of treating sick sinus syndrome with levosimendan |
| 06/28/2005 | US6911199 Targeted adenovirus vectors for delivery of heterologous genes |
| 06/28/2005 | CA2146775C Novel vitamin d analogues |
| 06/24/2005 | CA2454456A1 Amino ceramide-like compounds and therapeutic methods of use |
| 06/23/2005 | WO2005030333A3 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2] [2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 06/23/2005 | WO2005016885A3 COMPOUNDS WITH COMBINED CALCIUM CHANNEL BLOCKER AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITIES FOR TREATMENT OF HEART DISEASE |
| 06/23/2005 | WO2004052366A9 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 06/23/2005 | US20050137263 e.g., 2-[(4-Ethyl-2-fluorophenyl)amino]-3,4-difluoro-N-(2-hydroxyethoxy)benzamide, is administered to treat arthritis |
| 06/23/2005 | US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic |
| 06/23/2005 | US20050137242 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments |
| 06/23/2005 | US20050137239 Thiazole derivatives |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137216 Heterocyclic sodium/proton exchange inhibitors and method |
| 06/23/2005 | US20050137214 Inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137200 Potassium channel modulators; antiarrhythmia agents |
| 06/23/2005 | US20050137198 Stable hydrazalazine pharmaceutical compositions |
| 06/23/2005 | US20050137192 Use of compounds such as 4-bromo-9a-butyl-8-chloro-6-fluoro-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one to treat depression |
| 06/23/2005 | US20050137189 For therapy of Gram-positive bacterial infection |
| 06/23/2005 | US20050137188 Heterocyclic compounds |
| 06/23/2005 | US20050137180 Porphrins or azaporprins for photosensitizing therapy or photodetection with azaporprins for cardiovascular disorders and coordination with metals |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | US20050137148 treating an infectious disease associated with narrowing or obstruction of a body passageway by delivering to an external portion of the body passageway an antibiotic; infections such as pelvic inflammatory disease, urethritis, or tuberculosis |
| 06/23/2005 | US20050137144 synergistic admnistration of a weight-loss promoting anticonvulsant of of zonisamide or topiramate, and a norepinephrine or dopamine agonist; hypotensive, antidiabetic, anticholesterol agents |
| 06/23/2005 | US20050136537 Modulating sirtuin deacetylase protein; apoptosis; using flavone, stilbene, isoflavone, sphingosine; stroke; cardiovascular disorders; antiarthritic agents; Alzheimer's disease |
| 06/23/2005 | US20050136502 Treatment of disorders associated with elevated blood glucose or blood pressure |
| 06/23/2005 | US20050136138 mixtures of extracts from plants and vegetables such as ginger or onions, used to reduce serum levels of phosphatides and triglycerides, as dietetics, antilipemic and anticholesterol agents; cardiovascular disorders |
| 06/23/2005 | US20050136133 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 06/23/2005 | US20050136045 Can be administered by continuous infusion or by single intravenous bolus injection; use in the treatment of arterial thrombosis and for treating myocardial infarction; reduced antigenicity and immunogenicity as compared to wild-type staphylokinase |
| 06/23/2005 | DE60108272T2 Pharmazeutische zusammensetzung enthaltend (-)-secoisolariciresinol A pharmaceutical composition comprising (-) - Secoisolariciresinol |
| 06/23/2005 | CA2490218A1 Extracorporeal photopheresis in combination with anti-tnf treatment |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544295A1 Salt-inducible kinases 2 and use thereof |
| 06/22/2005 | EP1544281A1 Fat composition |
| 06/22/2005 | EP1544214A1 Non-neutralizing anti-apc antibodies |
| 06/22/2005 | EP1544208A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 06/22/2005 | EP1544201A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 06/22/2005 | EP1544200A1 1,2,4 -TRIAZOLO 1,5-c PYRIMIDINE DERIVATIVE |
| 06/22/2005 | EP1544198A1 A process for the preparation of crystalline losartan potassium |
| 06/22/2005 | EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 06/22/2005 | EP1543834A1 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 06/22/2005 | EP1543824A2 Thiazole derivatives to counter advanced glycation |
| 06/22/2005 | EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 06/22/2005 | EP1543025A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543003A2 Imidazo[1,2-a]pyridines |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |